BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10184452)

  • 1. FTC, Justice ask for clarification in Marshfield case.
    Taulbee P
    Healthc Syst Strategy Rep; 1995 Oct; 12(21):1-2. PubMed ID: 10184452
    [No Abstract]   [Full Text] [Related]  

  • 2. The minefield after Marshfield: how to avoid antitrust violations.
    Caesar NB
    Manag Care; 1995 Aug; 4(8):40-5. PubMed ID: 10145014
    [No Abstract]   [Full Text] [Related]  

  • 3. The Marshfield Clinic case: the sound of a broken record.
    McDonald K
    Ann Health Law; 1996; (5):1-31. PubMed ID: 10184656
    [No Abstract]   [Full Text] [Related]  

  • 4. Court overturns jury's verdict on Blue Cross antitrust violation claim.
    Kazon PM
    Bus Health; 1988 Nov; 6(1):44-5. PubMed ID: 10290529
    [No Abstract]   [Full Text] [Related]  

  • 5. Is this group an illegal doctor monopoly?
    Slomski AJ
    Med Econ; 1994 Sep; 71(18):64-6, 69-70, 72 passim. PubMed ID: 10136387
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitrust verdict in Marshfield Clinic case still ominous.
    Lutes ME; Vanderbilt TB
    Physician Exec; 1995 May; 21(5):25-6. PubMed ID: 10184494
    [No Abstract]   [Full Text] [Related]  

  • 7. "Blues interfered illegally with HMO.".
    Burda D
    Mod Healthc; 1987 Nov; 17(24):12. PubMed ID: 10284683
    [No Abstract]   [Full Text] [Related]  

  • 8. The saga of the Marshfield Clinic case.
    Hosp Health Netw; 1995 Nov; 69(22):22. PubMed ID: 8528310
    [No Abstract]   [Full Text] [Related]  

  • 9. Court amends its opinion in Marshfield Clinic ruling.
    Jaklevic MC
    Mod Healthc; 1995 Oct; 25(43):24. PubMed ID: 10152104
    [No Abstract]   [Full Text] [Related]  

  • 10. Marshfield verdict partly overturned; panel orders retrial.
    Jaklevic MC
    Mod Healthc; 1995 Sep; 25(39):4-5. PubMed ID: 10151421
    [No Abstract]   [Full Text] [Related]  

  • 11. Marshfield Clinic, physician networks, and the exercise of monopoly power.
    Greenberg W
    Health Serv Res; 1998 Dec; 33(5 Pt 2):1461-76. PubMed ID: 9865229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feds challenge Marshfield ruling.
    Jaklevic MC
    Mod Healthc; 1995 Oct; 25(41):33. PubMed ID: 10152052
    [No Abstract]   [Full Text] [Related]  

  • 13. High court's snub brings Wis. antitrust case to close.
    Jaklevic MC
    Mod Healthc; 1996 Mar; 26(13):6. PubMed ID: 10156135
    [No Abstract]   [Full Text] [Related]  

  • 14. Minimizing antitrust risks of Blue Cross and Blue Shield plans.
    Steele CJ
    J Contemp Health Law Policy; 1988; 4():227-72. PubMed ID: 10288422
    [No Abstract]   [Full Text] [Related]  

  • 15. Blues' discount policy seen as antitrust issue.
    Burda D
    Hospitals; 1986 Nov; 60(21):36. PubMed ID: 3770662
    [No Abstract]   [Full Text] [Related]  

  • 16. Health maintenance organizations and the specter of antitrust law.
    Ferrari BT; Sponsler TH
    Spec Law Dig Health Care (Mon); 1988 Jan; 9(7):7-34. PubMed ID: 10285562
    [No Abstract]   [Full Text] [Related]  

  • 17. Judge Posner's RFP: antitrust law and managed care.
    Sage WM
    Health Aff (Millwood); 1997; 16(6):44-61. PubMed ID: 9444808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Don't fence us in. The Marshfield Clinic ruling may be bad news for integrated delivery.
    Barnett AA
    Hosp Health Netw; 1995 May; 69(9):36-8, 40. PubMed ID: 7728163
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitrust assault on hospital-Blue Cross relations.
    Davis CD
    Tex Hosp; 1984 Feb; 39(9):46-7. PubMed ID: 10278223
    [No Abstract]   [Full Text] [Related]  

  • 20. Washington turns up antitrust heat on doctors.
    Slomski AJ
    Med Econ; 1991 Aug; 68(15):42-8. PubMed ID: 10112155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.